Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A

References

• Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101:1936–46.
   PubMed Web of Science ®Google Scholar
• Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood. 1990;76:1464–72.
   PubMed Web of Science ®Google Scholar
• Blazar BR, Murphy WJ. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci. 2005;360:1747–67.
   PubMed Web of Science ®Google Scholar
• Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296–307.
   PubMed Web of Science ®Google Scholar
• Huang WH, Zhang R, Guo BL, Si JP. Study on total alkaloids content and its influential factors in medicinal materials of Tripterygium. Zhongguo Zhong Yao Za Zhi. 2008;33:15–8.
   PubMedGoogle Scholar
• Cheng DW, Zou Y, Qian N, Wang CL, Tian YB, Wang DL, et al. Effects of compound preparation of Cordyceps sinensis and Tripterygium hypoglaucum on survival time of pigskin after allogeneic transplantation. Zhong Xi Yi Jie He Xue Bao. 2006;4:185–8.
   PubMedGoogle Scholar
• Liu SX, Cao J, Yuan J, Huang P, Shua PQ, Honma M. Effects of total alkaloids of Tripterygium hypoglaucum Hutch on tk gene of mouse lymphoma cells. Zhongguo Zhong Yao Za Zhi. 2003;28:954–7.
   PubMedGoogle Scholar
• Zhuang WJ, Fong CC, Cao J, Ao L, Leung CH, Cheung HY, et al. Involvement of NF-kappaB and c-myc signaling pathways in the apoptosis of HL-60 cells induced by alkaloids of Tripterygium hypoglaucum (level.) Hutch. Phytomedicine. 2004;11:295–302.
   PubMed Web of Science ®Google Scholar
• Pu LX, Zhang TM. Effects of triptolide on T lymphocyte functions in mice. Zhongguo Yao Li Xue Bao. 1990;11:76–9.
   PubMed Web of Science ®Google Scholar
• Fujita R, Duan H, Takaishi Y. Terpenoids from Tripterigyum hypoglaucum. Phytochemistry. 2000;53:715–22.
   PubMed Web of Science ®Google Scholar
• Zhong J, Xian D, Xu Y, Liu J. Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria. J Altern Complement Med. 2011;17:459–64.
   PubMed Web of Science ®Google Scholar
• Wu X, Xu J, Luo X. Effects of Tripterygium hypoglaucum on serum IL-1, IL-6, and TNF-alpha in chronic nephritis rats. Zhongguo Zhong Yao Za Zhi. 2010;35:3354–6.
   PubMedGoogle Scholar
• Kaplan DH, Anderson BE, McNiff JM, Jain D, Shlomchik MJ, Shlomchik WD. Target antigens determine graft-versus-host disease phenotype. J Immunol. 2004;173:5467–75.
   PubMed Web of Science ®Google Scholar
• Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood. 1992;80:2964–8.
   PubMed Web of Science ®Google Scholar
• Pollack BP, Sapkota B, Cartee TV. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clin Cancer Res. 2011;17:4400–13.
   PubMed Web of Science ®Google Scholar
• Raju K, Rabinovich BA, Radvanyi LG, Spaner D, Miller RG. A central role for IL-2 in fate determination of mature T cells–I: role in determining the Th1/Th2 profile in primary T cell cultures. Int Immunol. 2001;13:1453–9.
   PubMed Web of Science ®Google Scholar
• Poudrier J, Owens T. Th1 and Th2 help for B cells: differential capacity for induction of autonomous responsiveness to IL-2. Int Immunol. 1995;7:1021–7.
   PubMed Web of Science ®Google Scholar
• Wan CF, Li ZH, Xu GJ, Liu SS, Qi XY. Effects of depressive disorder on monocytic expression of CD(40) and plasma IL-8 concentration in senile coronary heart disease patients. Zhonghua Yi Xue Za Zhi. 2011;91(35):2459–63.
   PubMedGoogle Scholar
• Hess AD, Fischer AC, Beschorner WE. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets. J Immunol. 1990;145:526–33.
   PubMed Web of Science ®Google Scholar
• Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006;108:1291–7.
   PubMed Web of Science ®Google Scholar
• Wolf M, Schimpl A, Hunig T. Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol. 2001;31:1637–45.
   PubMed Web of Science ®Google Scholar
• Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, et al. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol. 2010;185:3866–72.
   PubMed Web of Science ®Google Scholar
• Vela-Ojeda J, Montiel-Cervantes L, Granados-Lara P, Reyes-Maldonado E, Garcia- Latorre E, Garcia-Chavez J, et al. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Stem Cells Dev. 2010;19:333–40.
   PubMed Web of Science ®Google Scholar
• Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, et al. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood. 2006;107:1717–23.
   PubMed Web of Science ®Google Scholar
• Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol. 2001;167:6312–20.
   PubMed Web of Science ®Google Scholar
• Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood. 2004;104:2187–93.
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723–35.
   PubMed Web of Science ®Google Scholar